drugset
drugset / Trial / NCT06493968

Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy

NCT06493968 ↗

Recruiting 70 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.

Timeline

Start
2024-07-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Intravenous

Indications

placenta accreta